|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Chronic care facilities, 61-62 Chronic progressive myelopathy, 233-234 Clostridium botulinum, 66 Clostridium difficile, 205 Codex Alimentarius, 68 Cofactors in disease, microbes as, 102-106 Connecticut, Lyme disease outbreak, 73-74 Coordination, see Organizational factors Costs and cost effectiveness, 15, 138-139, 169 measles immunization, 138, 139 vector control, 166 Council of State and Territorial Epidemiologists, 118-119 Cowpox, 24-25 Crimean-Congo hemorrhagic fever virus, 220-221 Cryptococcus spp., 251-252 Cryptosporidium, 252-253 Culiseta melanura, 30 D Dams, 71-72 National Nosocomial Infections Surveillance System (NNISS), 4, 58 , 121-122 National Notifiable Diseases Surveillance System (NNDSS), 3, 118- 120 Dengue, 30, 44, 49-51, 78, 221-222 Department of Defense (DoD), 151-152 overseas labs, 5, 9-10, 126, 127, 148-149, 261 Diama Dam, 71-72 Diarrheal diseases, 130-131, 239-240 Diet, 69 Disasters, 71 Drought, 64 agricultural use, 64 antiviral, 98-100 and Helicobacter pyroli, 29 and HIV, 100 resistance to, 29, 31-32, 58-59, 64, 92-101, 159-160 see also Acyclovir; Beta-lactam antibiotics; Foscarnet; Methicillin; Penicillin; Vancomycin Duodenal ulcers, 28-29 E Eastern equine encephalitis, 30 Economic factors, 33 pesticide development, 14, 164-165 vaccine development, 11-12, 152, 153, 154-155 see also Costs and cost effectiveness Education and training international coordination, 8-9
|
|
|||||||||||||||
